1. Aiello, L.P., R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, S.T. Shah, L.R. Pasquale, H. Thieme, M.A. Iwamoto, and J.E. Park. 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 331: 1480–1487.
2. Balupuri, A., C.G. Gadhe, P.K. Balasubramanian, G. Kothandan, and S.J. Cho. 2013. In silico study on indole derivatives as anti HIV-1 agents: A combined docking, molecular dynamics and 3D-QSAR study. Archives of Pharmacal Research 37: 1–15.
3. Balupuri, A., P. Balasubramanian, C. Gadhe, and S. Cho. 2014. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors. SAR QSAR in Environmental Research. doi: 10.1080/1062936X.2014.923040 .
4. Beebe, J.S., J.P. Jani, E. Knauth, P. Goodwin, C. Higdon, A.M. Rossi, E. Emerson, M. Finkelstein, E. Floyd, and S. Harriman. 2003. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Cancer Research 63: 7301–7309.
5. Berthod, H., C. Giessner-Prettre, and A. Pullman. 1967. Sur les rÔles respectifs des électrons σ et π dans les propriétés des dérivés halogénés des molécules conjuguées. Application Á l’étude de l’uracile et du fluorouracile. Theoretica Chimica Acta 8: 212–222.